Published in Virology on October 01, 1989
Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu Rev Microbiol (2002) 2.93
Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus. J Virol (2000) 2.74
Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol (2000) 2.62
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol (2003) 2.51
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol (1996) 2.23
Recombination in circulating enteroviruses. J Virol (2003) 2.08
Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol (2000) 2.00
Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees. J Virol (2001) 1.75
Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol (1995) 1.63
High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J Virol (1994) 1.52
Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions. J Virol (1994) 1.48
An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain. J Virol (1991) 1.31
Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. J Virol (2002) 1.24
WIN 52035-dependent human rhinovirus 16: assembly deficiency caused by mutations near the canyon surface. J Virol (1998) 1.24
A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol (2005) 1.23
Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis. J Virol (1997) 1.19
Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus. J Virol (1995) 1.12
Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication. J Virol (2006) 1.11
Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry. J Virol (2015) 0.99
Epidemics to eradication: the modern history of poliomyelitis. Virol J (2007) 0.96
Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties. J Virol (2006) 0.96
Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus. J Virol (1995) 0.91
Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus. Antimicrob Agents Chemother (2004) 0.90
Three amino acid mutations (F51L, T59A, and S390L) in the capsid protein of the hepatitis E virus collectively contribute to virus attenuation. J Virol (2011) 0.85
Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria. J Virol (2015) 0.83
Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples. J Clin Microbiol (2006) 0.82
Experimental evolution alters the rate and temporal pattern of population growth in Batrachochytrium dendrobatidis, a lethal fungal pathogen of amphibians. Ecol Evol (2014) 0.81
Coxsackievirus A9 VP1 mutants with enhanced or hindered A particle formation and decreased infectivity. J Virol (2001) 0.80
Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine. PLoS Pathog (2016) 0.76
Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis. BMC Infect Dis (2016) 0.75
Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains. Eur J Clin Microbiol Infect Dis (2010) 0.75
Human BSE. Nature (1997) 11.79
Chlamydial infection. Isolation of Chlamydia from patients with non-specific genital infection. Br J Vener Dis (1972) 7.92
Laboratory procedures for the isolation of chlamydia trachomatis from the human genital tract. J Clin Pathol (1975) 6.22
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet (2001) 5.75
Chlamydial infection of the male urethra. Br J Vener Dis (1976) 4.61
Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98
Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64
Simplified serological test for antibodies to Chlamydia trachomatis. J Clin Microbiol (1976) 3.64
Chlamydial infections of the cervix. Br J Vener Dis (1974) 3.48
Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess (2007) 3.40
Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet (1993) 3.14
Infection with Chlamydia group A in men with urethritis due to Neisseria gonorrhoeae. J Infect Dis (1975) 3.06
An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature (1989) 3.01
Inheritance and effect on ripening of antisense polygalacturonase genes in transgenic tomatoes. Plant Mol Biol (1990) 2.95
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol (1989) 2.89
Universal prophylaxis for Chlamydia trachomatis and anaerobic vaginosis in women attending for suction termination of pregnancy: an audit of short-term health gains. Int J STD AIDS (1999) 2.88
Knowledge and attitude on screening mammography among low-literate, low-income women. Cancer (1996) 2.81
Infection of the uterine cervix with Chlamydia trachomatis. J Infect Dis (1978) 2.36
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA (1999) 2.12
Autologous blood transfusion in total knee replacement surgery. Br J Anaesth (2001) 2.11
Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine. Lancet (1991) 2.10
A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technol Assess (2013) 2.09
The lack of effect of ampicillin plus probenecid given for genital infections with Neisseria gonorrhoeae on associated infections with Chlamydia trachomatis. J Infect Dis (1976) 2.07
Multiple origins of cultivated grapevine (Vitis vinifera L. ssp. sativa) based on chloroplast DNA polymorphisms. Mol Ecol (2006) 2.02
Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J Gen Virol (1986) 1.99
Norwalk-like viruses: demonstration of genomic diversity by polymerase chain reaction. J Clin Microbiol (1993) 1.96
A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect Immun (1997) 1.84
CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine. Leukemia (2007) 1.79
Zygotic lethal mutations with maternal effect phenotypes in Drosophila melanogaster. II. Loci on the second and third chromosomes identified by P-element-induced mutations. Genetics (1996) 1.76
Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol (Oxf) (2001) 1.75
A polio immunization pamphlet with increased appeal and simplified language does not improve comprehension to an acceptable level. Patient Educ Couns (1998) 1.73
Tuberculosis and HIV infection. Lancet (1994) 1.70
Anti-thyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with anti-microsomal antibody. J Clin Endocrinol Metab (1985) 1.69
Purification and properties of a polyvinyl alcohol-degrading enzyme produced by a strain of Pseudomonas. Arch Biochem Biophys (1976) 1.66
Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta. EMBO J (2001) 1.65
Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology (1993) 1.64
Population requirement for adult critical-care beds: a prospective quantitative and qualitative study. Lancet (2000) 1.62
The sensitivity, specificity and predictive values of raised plasma metal ion levels in the diagnosis of adverse reaction to metal debris in symptomatic patients with a metal-on-metal arthroplasty of the hip. J Bone Joint Surg Br (2012) 1.62
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Improving patient education for patients with low literacy skills. Am Fam Physician (1996) 1.60
Self-regeneration of a Pd-perovskite catalyst for automotive emissions control. Nature (2002) 1.58
A randomised controlled trial comparing TVT, Pelvicol and autologous fascial slings for the treatment of stress urinary incontinence in women. BJOG (2010) 1.58
Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task. Mol Psychiatry (2010) 1.57
Relation between literacy and HIV treatment knowledge among patients on HAART regimens. AIDS Care (2005) 1.56
Mucosal damage and recovery of the intestine after prolonged preservation and transplantation in dogs. Transplantation (2001) 1.55
Isolation and characteristics of a ureolytic strain of Selenomonas ruminatium. J Dairy Sci (1974) 1.54
Control and manipulation of gene expression during tomato fruit ripening. Plant Mol Biol (1989) 1.53
SF-36 scores vary by method of administration: implications for study design. J Public Health Med (1999) 1.51
Bright solid-state sources of indistinguishable single photons. Nat Commun (2013) 1.51
The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure. Can J Cardiol (2003) 1.49
Arterial patterns in the hand based on a three-dimensional analysis of 220 cadaver hands. J Hand Surg Am (1988) 1.48
Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths. J Infect Dis (1999) 1.48
The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3. J Gen Virol (1989) 1.46
The 5' noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology (1991) 1.45
Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract (2001) 1.45
Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J Virol (1990) 1.45
Parent comprehension of polio vaccine information pamphlets. Pediatrics (1996) 1.44
Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine. J Gen Virol (1995) 1.44
A longitudinal study of tooth wear in orthodontically treated patients. Am J Orthod Dentofacial Orthop (1997) 1.43
Management of atrial fibrillation in the post-thyrotoxic state. Am J Med (1982) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent. J Immunol (2001) 1.39
Chlamydial infection. Isolation of Chlamydia from patients with non-specific genital infection. 1972. Sex Transm Infect (2000) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response. J Exp Med (1992) 1.38
Genome-sequence-based fluorescent amplified-fragment length polymorphism analysis of Mycobacterium tuberculosis. J Clin Microbiol (2000) 1.36
Treating the right patient at the right time: access to heart failure care. Can J Cardiol (2006) 1.36
Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias. Eur Respir J (2003) 1.35
Serological studies on the role of Chlamydia in the aetiology of non-specific urethritis. Br J Vener Dis (1974) 1.35
Influenza virus RNA polymerase PA subunit is a novel serine protease with Ser624 at the active site. Genes Cells (2001) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain. J Virol (1991) 1.31
Role of Arg-gingipain A in virulence of Porphyromonas gingivalis. Infect Immun (1998) 1.29
Practice characteristics associated with audit activity: a medical audit advisory group survey. Br J Gen Pract (1994) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. II. Evaluation in adult volunteers. J Infect Dis (1980) 1.27
Bone densitometry in Canadian children 8-17 years of Age. Calcif Tissue Int (1996) 1.26
Fluorescent amplified-fragment length polymorphism genotyping of Neisseria meningitidis identifies clones associated with invasive disease. J Clin Microbiol (2000) 1.25
Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping. J Gen Virol (1982) 1.25
Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf) (1984) 1.22
Minocycline in the treatment of nongonococcal urethritis: its effect on Chlamydia trachomatis. J Am Vener Dis Assoc (1975) 1.21
Cell salvage auto transfusion in total knee replacement surgery. Transfus Med (1997) 1.21
Analysis of promoters in Borrelia burgdorferi by use of a transiently expressed reporter gene. J Bacteriol (1997) 1.21
Comparison of gastrointestinal tolerance to two enteral feeding protocols in critically ill patients: a prospective, randomized controlled trial. JPEN J Parenter Enteral Nutr (2001) 1.21
Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Lett (1997) 1.20
[Left-sided gallbladder with accessory liver accompanied by intrahepatic cholangiocarcinoma]. Nihon Geka Gakkai Zasshi (1992) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis (1994) 1.18
Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses. Eur J Biochem (1983) 1.18
Modification of the home environment for the reduction of injuries. Cochrane Database Syst Rev (2006) 1.17
Studies in man with cold-recombinant influenza virus (H1N1) live vaccines. J Med Virol (1980) 1.16
Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model. J Infect Dis (1998) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13